Hematology Analyzers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hematology Analyzers Pipeline Market Report Overview

Hematology Analyzers consist of analytical laboratory equipment that is used to perform tests related to blood and blood components. These analyzers are also used to identify and determine the morphology of blood and blood-forming cells such as white blood cells, lymphocytes, monocytes, neutrophils, eosinophils, and basophils. Hematology analyzers utilize various technological solutions to recognize cell types in a blood sample and to count them individually to generate a complete blood count (CBC) with differential.

The Hematology Analyzers pipeline market research report provides comprehensive information about the Hematology Analyzers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Territories ·        The US

·        China

·        Europe

·        Global

·        Australia

Key Segments ·        Bench Top POC Hematology Analyzers

·        Medium-throughput Fixed Hematology Analyzers

Key Regulatory Paths ·        510(k)

·        NMPA

·        CE-IVD

·        TGA

·        Ninsho

Leading Companies ·        Alentic Microscience Inc

·        Analyticon Biotechnologies AG

·        Antigon SA

·        Apollo Medical Devices LLC

·        Ativa Medical Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hematology Analyzers Pipeline Market Segmentation by Segments

Some of the key segments in the Hematology Analyzers market are Bench Top POC Hematology Analyzers and Medium-throughput Fixed Hematology Analyzers. As of November 2023, Bench Top POC Hematology Analyzers has the highest number of pipeline products.

Hematology Analyzers Pipeline Market Analysis by Segments, 2023 (%)

Hematology Analyzers Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segments Insights into the Hematology Analyzers Pipeline Market

Download a Free Report Sample

Hematology Analyzers Pipeline Market Segmentation by Territories

Some of the key territories in the Hematology Analyzers market are the US, China, Europe, Global, and Australia among others. As of November 2023, the US has the highest number of pipeline products.

Hematology Analyzers Pipeline Market Analysis by Territories, 2023 (%)

Hematology Analyzers Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Hematology Analyzers Pipeline Market

Download a Free Report Sample

Hematology Analyzers Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Hematology Analyzers pipeline market are 510(k), NMPA, CE-IVD, TGA, and Ninsho. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Hematology Analyzers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Hematology Analyzers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Hematology Analyzers Pipeline Market

Download a Free Report Sample

Hematology Analyzers Pipeline Market – Competitive Landscape

Some of the key companies in the Hematology Analyzers pipeline market are:

  • Alentic Microscience Inc
  • Analyticon Biotechnologies AG
  • Antigon SA
  • Apollo Medical Devices LLC
  • Ativa Medical Inc

Analyticon Biotechnologies AG: It is a subsidiary of Analyticon Discovery GmbH, is a medical device company that develops, manufactures, and distributes diagnostic systems. The company provides products in the areas of urine diagnostics and hematology. Its urine diagnostics segment includes analyzers, urine test strips, controls, and vet diagnostics. Analyticon’s hematology segment includes an analyzer, reagents, and controls. The company offers services such as contract services support training and partner sales consulting services. The company’s products are used as diagnostic solutions in physician’s offices, hospitals, and clinical laboratories. It distributes products in Europe, the Middle East, Africa, and the Americas through a network of distributors. Analyticon is headquartered in Lichtenfels, Germany.

Hematology Analyzers Pipeline Market Analysis by Companies, 2023

Hematology Analyzers Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Hematology Analyzers Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Hematology Analyzers Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Global
  • Australia

Hematology Analyzers Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • CE-IVD
  • TGA
  • NINSHO

Scope

This report provides:

  • Extensive coverage of the Hematology Analyzers under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Hematology Analyzers under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Alentic Microscience Inc
Analyticon Biotechnologies AG
Antigon SA
Apollo Medical Devices LLC
Ativa Medical Inc
Baebies Inc
Bio-AMD Inc
Cellmic LLC
Daxor Corp
Diatron Medical Instruments Limited
iFirst Medical Technologies LLC
Ionu Biosystems
IRIS International Inc
I-Sens Inc
Meridian Bioscience Inc
MicroX Labs Inc
NGeneBio Co Ltd
Quotient Ltd
Rutgers The State University of New Jersey
Siemens Healthcare Diagnostics Inc
Sysmex Corp
The University of British Columbia
Trinity Biotech Plc

Table of Contents

1 Table of Contents 3_x000D_

1.1 List of Tables 6_x000D_

1.2 List of Figures 8_x000D_

2 Introduction 9_x000D_

2.1 Hematology Analyzers Overview 9_x000D_

3 Products under Development 10_x000D_

3.1 Hematology Analyzers – Pipeline Products by Stage of Development 10_x000D_

3.2 Hematology Analyzers – Pipeline Products by Segment 11_x000D_

3.3 Hematology Analyzers – Pipeline Products by Territory 12_x000D_

3.4 Hematology Analyzers – Pipeline Products by Regulatory Path 14_x000D_

3.5 Hematology Analyzers – Pipeline Products by Estimated Approval Date 15_x000D_

3.6 Hematology Analyzers – Ongoing Clinical Trials 16_x000D_

4 Hematology Analyzers – Pipeline Products under Development by Companies 17_x000D_

4.1 Hematology Analyzers Companies – Pipeline Products by Stage of Development 17_x000D_

4.2 Hematology Analyzers – Pipeline Products by Stage of Development 18_x000D_

5 Hematology Analyzers Companies and Product Overview 19_x000D_

5.1 Alentic Microscience Inc Company Overview 19_x000D_

5.1.1 Alentic Microscience Inc Pipeline Products & Ongoing Clinical Trials Overview 19_x000D_

5.2 Analyticon Biotechnologies AG Company Overview 20_x000D_

5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 20_x000D_

5.3 Antigon SA Company Overview 21_x000D_

5.3.1 Antigon SA Pipeline Products & Ongoing Clinical Trials Overview 21_x000D_

5.4 Apollo Medical Devices LLC Company Overview 22_x000D_

5.4.1 Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 22_x000D_

5.5 Ativa Medical Inc Company Overview 23_x000D_

5.5.1 Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23_x000D_

5.6 Baebies Inc Company Overview 24_x000D_

5.6.1 Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview 24_x000D_

5.7 Bio-AMD Inc Company Overview 25_x000D_

5.7.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 25_x000D_

5.8 Cellmic LLC Company Overview 26_x000D_

5.8.1 Cellmic LLC Pipeline Products & Ongoing Clinical Trials Overview 26_x000D_

5.9 Daxor Corp Company Overview 27_x000D_

5.9.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 27_x000D_

5.10 Diatron Medical Instruments Limited Company Overview 30_x000D_

5.10.1 Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 30_x000D_

5.11 iFirst Medical Technologies LLC Company Overview 33_x000D_

5.11.1 iFirst Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 33_x000D_

5.12 Ionu Biosystems Company Overview 34_x000D_

5.12.1 Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview 34_x000D_

5.13 IRIS International Inc Company Overview 35_x000D_

5.13.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 35_x000D_

5.14 I-Sens Inc Company Overview 36_x000D_

5.14.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 36_x000D_

5.15 Meridian Bioscience Inc Company Overview 37_x000D_

5.15.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 37_x000D_

5.16 MicroX Labs Inc Company Overview 38_x000D_

5.16.1 MicroX Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 38_x000D_

5.17 NGeneBio Co Ltd Company Overview 41_x000D_

5.17.1 NGeneBio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41_x000D_

5.18 Quotient Ltd Company Overview 42_x000D_

5.18.1 Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview 42_x000D_

5.19 Rutgers The State University of New Jersey Company Overview 45_x000D_

5.19.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 45_x000D_

5.20 Siemens Healthcare Diagnostics Inc Company Overview 46_x000D_

5.20.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 46_x000D_

5.21 Sysmex Corp Company Overview 47_x000D_

5.21.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 47_x000D_

5.22 The University of British Columbia Company Overview 50_x000D_

5.22.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 50_x000D_

5.23 Trinity Biotech Plc Company Overview 52_x000D_

5.23.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 52_x000D_

6 Hematology Analyzers- Recent Developments 53_x000D_

6.1 Nov 02, 2023: Haemonetics Announces Second Quarter Fiscal Year 2024 53_x000D_

6.2 Oct 31, 2023: Samsung Electronics Reports Q3 2023 Results 53_x000D_

6.3 Oct 27, 2023: Tokuyama Corp Announces Consolidated Financial Statements for the Second Quarter Fiscal 2023 57_x000D_

6.4 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range 58_x000D_

6.5 Oct 11, 2023: CellaVision Invitation to Presentation for the Third Quarter 2023 on October 25, at 11:00 CEST 60_x000D_

6.6 Oct 11, 2023: Eurobio Scientific : Results for the First Half of 2023 60_x000D_

6.7 Sep 11, 2023: Dirui Industrial Appoints Lin Maoliang as Non-Independent Directors 62_x000D_

6.8 Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference 62_x000D_

6.9 Jul 27, 2023: Tokuyama Announces First Quarter Results of Fiscal 2023 62_x000D_

6.10 Jul 12, 2023: T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results 63_x000D_

6.11 Jul 10, 2023: Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2024 Results 64_x000D_

6.12 Jul 06, 2023: Trinity Biotech Announces Q1 2023 Financial Results 64_x000D_

6.13 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO 68_x000D_

6.14 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1 68_x000D_

6.15 May 15, 2023: T2 Biosystems postpones reporting of first quarter 2023 financial results 68_x000D_

6.16 May 11, 2023: Haemonetics announces fourth quarter fiscal year 2023 earnings 69_x000D_

6.17 May 05, 2023: CellaVision: Bulletin from annual general meeting 2023 69_x000D_

6.18 Apr 28, 2023: Biolidics Announces Annual General Meeting 70_x000D_

6.19 Apr 28, 2023: Biolidics Announces Annual General Meeting 70_x000D_

6.20 Apr 25, 2023: Haemonetics sets date for publishing fourth quarter and fiscal year 2023 results: May 11, 2023 70_x000D_

6.21 Apr 21, 2023: Invitation to presentation of the CellaVision report for the first quarter 2023 on May 4, at 11:00 CEST 70_x000D_

6.22 Apr 05, 2023: Eurobio Scientific Announces 2022 Annual Results 71_x000D_

6.23 Apr 03, 2023: Cellavision Notice Of Annual General Meeting 72_x000D_

6.24 Mar 31, 2023: Biolidics Announces Appointment of Independent Director 78_x000D_

6.25 Mar 28, 2023: EKF Diagnostics Holdings Announces its final results for the year ended 31 December 2022 78_x000D_

6.26 Mar 13, 2023: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results 80_x000D_

6.27 Mar 02, 2023: Daxor to Report Fiscal Year 2022 Financial Results on Wednesday, March 1, 2023 and Provide Corporate Update 81_x000D_

6.28 Feb 27, 2023: Tokuyama Corp. Notice concerning Change of Representative Director 81_x000D_

6.29 Feb 16, 2023: Samsung Electronics Announces 2022 Consolidated Financial Statements 82_x000D_

6.30 Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023 83_x000D_

6.31 Feb 08, 2023: Eurobio Scientific formalises the appointment of Anne-Sophie Herelle as Group CFO 86_x000D_

6.32 Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors 86_x000D_

6.33 Feb 07, 2023: Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2023 Results; Updates Fiscal 2023 Guidance 86_x000D_

6.34 Jan 31, 2023: Tokuyama Announces Summary of Consolidated Financial Statements for the Third Quarter Fiscal 2022 87_x000D_

6.35 Jan 24, 2023: CellaVision’s Invitation for presentation of the report for the fourth quarter 2022 on February 7, at 11:00 CET 88_x000D_

6.36 Jan 23, 2023: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results 88_x000D_

6.37 Jan 16, 2023: Samsung hires ex-Yogiyo CEO to lead online sales as rivals axe jobs 89_x000D_

6.38 Jan 13, 2023: Daxor Corporation to exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress 89_x000D_

6.39 Jan 06, 2023: Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023 89_x000D_

6.40 Dec 30, 2022: Samsung Appoints Hubert H. Lee To Lead Its MX Design Team 89_x000D_

7 Appendix 91_x000D_

7.1 Methodology 91_x000D_

7.2 About GlobalData 94_x000D_

7.3 Contact Us 94_x000D_

7.4 Disclaimer 94_x000D_

Table

Hematology Analyzers – Pipeline Products by Stage of Development 10_x000D_

Hematology Analyzers – Pipeline Products by Segment 11_x000D_

Hematology Analyzers – Pipeline Products by Territory 12_x000D_

Hematology Analyzers – Pipeline Products by Regulatory Path 14_x000D_

Hematology Analyzers – Pipeline Products by Estimated Approval Date 15_x000D_

Hematology Analyzers – Ongoing Clinical Trials 16_x000D_

Hematology Analyzers Companies – Pipeline Products by Stage of Development 17_x000D_

Hematology Analyzers – Pipeline Products by Stage of Development 18_x000D_

Alentic Microscience Inc Pipeline Products & Ongoing Clinical Trials Overview 19_x000D_

Prospector Point-of-Care Complete Blood Cell Counts Analyzer – Product Status 19_x000D_

Prospector Point-of-Care Complete Blood Cell Counts Analyzer – Product Description 19_x000D_

Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 20_x000D_

Hemolyzer 5 – Product Status 20_x000D_

Hemolyzer 5 – Product Description 20_x000D_

Antigon SA Pipeline Products & Ongoing Clinical Trials Overview 21_x000D_

ISABO Device – Product Status 21_x000D_

ISABO Device – Product Description 21_x000D_

Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 22_x000D_

Portable Blood Analysis System – Product Status 22_x000D_

Portable Blood Analysis System – Product Description 22_x000D_

Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23_x000D_

Ativa MicroLab System – Product Status 23_x000D_

Ativa MicroLab System – Product Description 23_x000D_

Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview 24_x000D_

Anticoagulation Monitor – Product Status 24_x000D_

Anticoagulation Monitor – Product Description 24_x000D_

Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 25_x000D_

Blood Coagulation Monitor – Product Status 25_x000D_

Blood Coagulation Monitor – Product Description 25_x000D_

Cellmic LLC Pipeline Products & Ongoing Clinical Trials Overview 26_x000D_

LUCAS – Product Status 26_x000D_

LUCAS – Product Description 26_x000D_

Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 27_x000D_

BVA-100 – Acute Decompensated Heart Failure – Product Status 27_x000D_

BVA-100 – Acute Decompensated Heart Failure – Product Description 27_x000D_

BVA-100 – POTS – Product Status 28_x000D_

BVA-100 – POTS – Product Description 28_x000D_

BVA-100 Combat Casualty Care – Product Status 28_x000D_

BVA-100 Combat Casualty Care – Product Description 29_x000D_

Next Gen BVA-100 – Product Status 29_x000D_

Next Gen BVA-100 – Product Description 29_x000D_

Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 30_x000D_

Abacus 380 – Product Status 30_x000D_

Abacus 380 – Product Description 31_x000D_

Diatron Aquila – Product Status 31_x000D_

Diatron Aquila – Product Description 32_x000D_

iFirst Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 33_x000D_

iFirst Analyzer – Product Status 33_x000D_

iFirst Analyzer – Product Description 33_x000D_

Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview 34_x000D_

Fluorescent Smart Phone Blood Analyzer – Product Status 34_x000D_

Fluorescent Smart Phone Blood Analyzer – Product Description 34_x000D_

IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 35_x000D_

3GEMS Hematology Analyzer – Product Status 35_x000D_

3GEMS Hematology Analyzer – Product Description 35_x000D_

I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 36_x000D_

i-Smart 30 – Mg – Product Status 36_x000D_

i-Smart 30 – Mg – Product Description 36_x000D_

Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 37_x000D_

Next Generation Pediatric Blood Chemistry Analyzer – Product Status 37_x000D_

Next Generation Pediatric Blood Chemistry Analyzer – Product Description 37_x000D_

MicroX Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 38_x000D_

Complete Blood Count Homecare Device – Cancer – Product Status 38_x000D_

Complete Blood Count Homecare Device – Cancer – Product Description 38_x000D_

Complete Blood Count Homecare Device – Flu – Product Status 39_x000D_

Complete Blood Count Homecare Device – Flu – Product Description 39_x000D_

Complete Blood Count Homecare Device – Infertility – Product Status 39_x000D_

Complete Blood Count Homecare Device – Infertility – Product Description 40_x000D_

NGeneBio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41_x000D_

Easy HLA Analyzer – Product Status 41_x000D_

Easy HLA Analyzer – Product Description 41_x000D_

Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview 42_x000D_

MosaiQ – Product Status 42_x000D_

MosaiQ – Product Description 42_x000D_

Quotient Ltd – Ongoing Clinical Trials Overview 43_x000D_

MosaiQ – Clinical Internal Evaluation of MosaiQ for Diagnosis of Blood Transfusion Diseases 44_x000D_

Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 45_x000D_

Automated Robotic Device – Blood Testing – Product Status 45_x000D_

Automated Robotic Device – Blood Testing – Product Description 45_x000D_

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 46_x000D_

ADCIA 2120 Hematology System – Product Status 46_x000D_

ADCIA 2120 Hematology System – Product Description 46_x000D_

Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 47_x000D_

Automated Hematology Analyzer XN-31 – Product Status 47_x000D_

Automated Hematology Analyzer XN-31 – Product Description 47_x000D_

Sysmex XQ-320 Automated Hematology Analyzer – Product Status 48_x000D_

Sysmex XQ-320 Automated Hematology Analyzer – Product Description 49_x000D_

The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 50_x000D_

Portable Hematology Analyzer – Product Status 50_x000D_

Portable Hematology Analyzer – Product Description 51_x000D_

Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 52_x000D_

Premier Resolution System – Product Status 52_x000D_

Premier Resolution System – Product Description 52_x000D_

Glossary 93_x000D_

Figures

Hematology Analyzers – Pipeline Products by Stage of Development 10_x000D_

Hematology Analyzers – Pipeline Products by Segment 11_x000D_

Hematology Analyzers – Pipeline Products by Territory 12_x000D_

Hematology Analyzers – Pipeline Products by Regulatory Path 14_x000D_

Hematology Analyzers – Pipeline Products by Estimated Approval Date 15_x000D_

Hematology Analyzers – Ongoing Clinical Trials 16_x000D_

Frequently asked questions

Hematology Analyzers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Hematology Analyzers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hematology Analyzers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Hematology Analyzers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.